X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES FDC LTD. JUBILANT LIFE SCIENCES/
FDC LTD.
 
P/E (TTM) x 15.2 18.9 80.3% View Chart
P/BV x 4.5 3.8 119.0% View Chart
Dividend Yield % 0.4 1.3 32.3%  

Financials

 JUBILANT LIFE SCIENCES   FDC LTD.
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
FDC LTD.
Mar-14
JUBILANT LIFE SCIENCES/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs187144 130.2%   
Low Rs6579 82.4%   
Sales per share (Unadj.) Rs364.347.6 766.0%  
Earnings per share (Unadj.) Rs6.87.6 90.0%  
Cash flow per share (Unadj.) Rs24.59.0 271.9%  
Dividends per share (Unadj.) Rs3.002.25 133.3%  
Dividend yield (eoy) %2.42.0 117.8%  
Book value per share (Unadj.) Rs164.947.5 346.9%  
Shares outstanding (eoy) m159.28177.83 89.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.32.3 14.8%   
Avg P/E ratio x18.414.6 125.8%  
P/CF ratio (eoy) x5.112.3 41.6%  
Price / Book Value ratio x0.82.3 32.6%  
Dividend payout %43.829.6 148.2%   
Avg Mkt Cap Rs m20,06119,784 101.4%   
No. of employees `0006.2NA-   
Total wages/salary Rs m11,0521,221 905.5%   
Avg. sales/employee Rs Th9,383.0NM-  
Avg. wages/employee Rs Th1,786.9NM-  
Avg. net profit/employee Rs Th176.3NM-  
INCOME DATA
Net Sales Rs m58,0348,459 686.1%  
Other income Rs m191394 48.4%   
Total revenues Rs m58,2248,852 657.7%   
Gross profit Rs m5,7862,070 279.5%  
Depreciation Rs m2,812249 1,128.7%   
Interest Rs m3,23731 10,439.2%   
Profit before tax Rs m-722,184 -3.3%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m696606 115.0%   
Profit after tax Rs m1,0901,353 80.6%  
Gross profit margin %10.024.5 40.7%  
Effective tax rate %-965.927.7 -3,482.9%   
Net profit margin %1.916.0 11.7%  
BALANCE SHEET DATA
Current assets Rs m29,2804,355 672.3%   
Current liabilities Rs m38,9121,792 2,171.5%   
Net working cap to sales %-16.630.3 -54.8%  
Current ratio x0.82.4 31.0%  
Inventory Days Days8444 189.8%  
Debtors Days Days5125 205.5%  
Net fixed assets Rs m55,7123,025 1,841.7%   
Share capital Rs m155179 86.5%   
"Free" reserves Rs m20,9688,243 254.4%   
Net worth Rs m26,2658,453 310.7%   
Long term debt Rs m17,16911 160,456.1%   
Total assets Rs m88,60610,557 839.3%  
Interest coverage x1.071.4 1.4%   
Debt to equity ratio x0.70 51,640.2%  
Sales to assets ratio x0.70.8 81.7%   
Return on assets %4.913.1 37.3%  
Return on equity %4.216.0 25.9%  
Return on capital %11.623.5 49.2%  
Exports to sales %37.813.3 284.0%   
Imports to sales %16.53.3 493.1%   
Exports (fob) Rs m21,9331,126 1,948.4%   
Imports (cif) Rs m9,567283 3,383.1%   
Fx inflow Rs m22,0041,146 1,919.9%   
Fx outflow Rs m11,749355 3,306.8%   
Net fx Rs m10,255791 1,296.8%   
CASH FLOW
From Operations Rs m8,0261,485 540.5%  
From Investments Rs m-1,744-620 281.5%  
From Financial Activity Rs m-4,447-753 591.0%  
Net Cashflow Rs m1,834113 1,626.3%  

Share Holding

Indian Promoters % 45.6 68.9 66.2%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 4.7 185.1%  
FIIs % 21.2 7.5 282.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 19.0 111.1%  
Shareholders   23,815 23,730 100.4%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   STRIDES PHARMA SCIENCE  ELDER PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare JUBILANT LIFE SCIENCES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Related Views on News

FDC LTD. Announces Quarterly Results (2QFY19); Net Profit Down 33.6% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, FDC LTD. has posted a net profit of Rs 431 m (down 33.6% YoY). Sales on the other hand came in at Rs 3 bn (down 12.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY19); Net Profit Up 67.2% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 67.2% YoY). Sales on the other hand came in at Rs 23 bn (up 38.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY18); Net Profit Up 1.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 1.4% YoY). Sales on the other hand came in at Rs 23 bn (up 37.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Dec 14, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS